Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)
Inhibin is a peptide that is an inhibitor of FSH synthesis and secretion, and participates in the regulation of the menstrual cycle.
Structure[]
Inhibin contains an alpha and beta subunit linked by disulfide bonds. Two forms of inhibin differ in their beta subunits (A or B), while their alpha subunits are identical. Inhibin belongs to the transforming growth factor-β (TGF-β) family.
Action[]
In women, FSH stimulates the secretion of inhibin from the granulosa cells of the ovary. In turn, inhibin suppresses FSH. Inhibin secretion is diminished by GnRH, and enhanced by insulin-like growth factor-1 (IGF-1). Inhibin B reaches a peak in the early- to mid-follicular phase, and a second peak at ovulation, in contrast to inhibin A, which reaches its peak in the mid-luteal phase. Inhibin is produced in the gonads, pituitary gland, placenta and other organs.
In men, it is a hormone that inhibits FSH production. It is secreted from the sustentacular cell, located in the seminiferous tubule inside the testes.
Activin[]
Activin is a related peptide that counteracts inhibin.
Prenatal Testing[]
Quantification of inhibin A is part of the prenatal quad screen that can be administered during pregnancy at a gestational age of 16-18 weeks. An elevated inhibin A (along with an increased beta-hCG, decreased AFP, and a decreased estriol) is [1] suggestive of the presence of a fetus with Downs syndrome. As a screening test, abnormal quad screen test results need to be followed up with more definitive tests.
External links[]
References[]
- ↑ , David A. Aitken, Ph.D., Euan M. Wallace, M.R.C.O.G., Jennifer A. Crossley, Ph.D., Ian A. Swanston, B.Sc., Yvonne van Pareren, M.Sc., Merel van Maarle, M.Sc., Nigel P. Groome, Ph.D., James N. Macri, Ph.D., and J. Michael Connor, M.D. (1996-05-09)Dimeric Inhibin A as a Marker for Down's Syndrome in Early Pregnancy. New England Journal of Medicine, The 334 (19): 1231-1236.
Endocrine system: hormones (Peptide hormones · Steroid hormones) | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endocrine glands |
| ||||||||||||||||||||||
| Non-end. glands |
Thymus: Thymosin (Thymosin α1, Thymosin beta) · Thymopoietin · Thymulin Digestive system: Stomach: gastrin · ghrelin · Duodenum: CCK · Incretins (GIP, GLP-1) · secretin · motilin · VIP · Ileum: enteroglucagon ·peptide YY · Liver/other: Insulin-like growth factor (IGF-1, IGF-2) Adipose tissue: leptin · adiponectin · resistin Skeleton: Osteocalcin Kidney: JGA (renin) · peritubular cells (EPO) · calcitriol · prostaglandin | ||||||||||||||||||||||
| {| class="navbox collapsible nowraplinks" style="margin:auto; " | |||||||||||||||||||||||
| |||||||||||||||||||||||
|}
Target-derived NGF, BDNF, NT-3
|}
Cell signaling: TGF beta signaling pathway | |
|---|---|
| TGF beta superfamily of ligands |
TGF beta family (TGF-β1, TGF-β2, TGF-β3) |
| TGF beta receptors |
TGFBR1: Activin type 1 receptors (ACVR1, ACVR1B, ACVR1C) - ACVRL1 - BMPR1 (BMPR1A - BMPR1B) |
| Transducers/SMAD |
R-SMAD (SMAD1, SMAD2, SMAD3, SMAD5, SMAD9) - I-SMAD (SMAD6, SMAD7) - SMAD4 |
| Ligand Inhibitors |
Cerberus - Chordin - DAN - Decorin - Follistatin - Gremlin - Lefty - LTBP1 - Noggin - THBS1 |
| Coreceptors |
BAMBI - Cripto |
| Other |
SARA |
de:Inhibin
fr:Inhibine
| This page uses Creative Commons Licensed content from Wikipedia (view authors). |